Toll Free : +1-855-465-4651 | (DE) : +49 322 210 92714 | (USA) : +1-386-310-3803 | Contact : sales@qygroup.biz

Search Market Research Reports from Top Publishers

Global and United States Aurora Kinase A Market 2018- Global Trends & Forecast to 2021

Mar-2018 | Published By : QYResearch | Category : Pharmaceuticals | Pages : 128

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE

Global and United States Aurora Kinase A Market 2018- Global Trends & Forecast to 2021

Mar-2018 | Published By : QYResearch | Category : Pharmaceuticals | Pages : 128 | Format : PDF

Summary

This report studies the Aurora Kinase A market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Aurora Kinase A market by product type and application/end industries.

The global Aurora Kinase A market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially the United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Aurora Kinase A.

United States plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of XX.

Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Aurora Kinase A in these regions, from 2013 to 2025 (forecast), covering
    United States
    North America
    Europe
    Asia-Pacific
    South America
    Middle East and Africa

The major players in global and United States market, including
    AbbVie Inc.
    Amgen Inc.
    Astex Pharmaceuticals, Inc.
    CASI Pharmaceuticals Inc.
    Merck & Co., Inc.
    Millennium Pharmaceuticals, Inc.
    Sanofi
    Sareum Holdings Plc
    Sigma-Tau S.p.A.
    Taiho Pharmaceutical Co., Ltd.
    Vertex Pharmaceuticals Incorporated
    Vichem Chemie Research Ltd.
On the basis of product, the market is primarily split into
    AMG-900
    Danusertib
    ENMD-2076
    Ilorasertib
    Others
On the basis on the end users/application, this report covers
    Ovarian Cancer
    Anaplastic Large Cell Lymphoma
    Brain Tumor
    Others
<pre></pre>


 Latest Research Reports